Hamps Bio Ltd

Hamps Bio Limited has re-appointed M/s Naviwala & Associates, Surat, as its Internal Auditor for the Financial Year 2026-27, effective from May 29, 2026. This decision was made during the Board of Directors meeting held on May 29, 2026, and complies with Regulation 30 of the Listing Regulations. Naviwala and Associates, founded in July 2020, has expertise in India's financial landscape.

Hamps Bio Ltd's Board of Directors approved the standalone and consolidated audited financial results for the half year and financial year ended March 31, 2026. The board also took note of the auditor’s report with an unmodified opinion issued by M/s MGHVS & ASSOCIATES. Additionally, M/s Naviwala & Associates, Surat, were appointed as the Internal Auditor for the Financial Year 2026-2027.

Hamps Bio Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the audited standalone and consolidated financial results for the half year and year ended March 31, 2026. The board will also consider the appointment of Naviwala & Associates as internal auditor for the financial year 2026-2027.

Hamps Bio Ltd has announced the closure of the trading window for all Designated Persons, Directors and their immediate relatives. The closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the Company's code of conduct. The trading window will remain closed from Wednesday, April 01, 2026 till 48 hours after the announcement/declaration of Audited Standalone and Consolidated Financial Results for half year and year ended on 31st March, 2026. The date of the Board Meeting at which the said results will be considered is yet to be intimated.

Hamps Bio Ltd has announced the completion of the acquisition of 100% equity shares of HSDL Innovative Private Limited. The total purchase consideration for this acquisition is INR 2,04,00,000. This acquisition has resulted in HSDL Innovative Private Limited becoming a Wholly Owned Subsidiary of Hamps Bio Ltd. The acquisition was completed on 25th March 2026. The necessary information has been provided to the Stock Exchange(s) as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Master Circular no. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026.

Hamps Bio Ltd., previously known as Hamps Bio Pvt. Ltd., has considered and approved the acquisition of 100% paid-up equity share capital of HSDL Innovative Private Limited for a total purchase consideration of INR 2,03,78,718.21 in cash. The acquisition will make HSDL Innovative Private Limited a Wholly Owned Subsidiary of Hamps Bio Ltd. The acquisition is expected to be completed within 60 days, and the Target Company is engaged in the business of freeze-drying food process and freeze-drying fruits, vegetables, herbs and ready to eat foods. The turnover of the Target Company during the last 3 financial years are as follow: 2022-23 Rs. 1,45,07,814.58/-, 2023-24 Rs. 1,84,96,852.58/- and 2024-25 Rs. 1,86,64,115.42/-.

Hamps Bio Ltd., previously known as Hamps Bio Pvt. Ltd., has approved the acquisition of 100% paid-up equity share capital of HSDL Innovative Private Limited for a total purchase consideration of INR 2,03,78,718.21. The acquisition will make HSDL Innovative Private Limited a Wholly Owned Subsidiary of Hamps Bio Ltd. The acquisition is expected to be completed within 60 days. HSDL Innovative Private Limited is engaged in the business of freeze-drying food process and freeze-drying fruits, vegetables, herbs and ready to eat foods.

Hamps Bio Ltd, formerly known as Hamps Bio Private Limited, released its unaudited financial results for the half-year ended on 30th September 2025. The Board of Directors approved these results during their meeting on 14th November 2025. The company's financial statements, prepared in accordance with Accounting Standard 25 and other accounting principles generally accepted in India, were reviewed by MGHVS & ASSOCIATES, the independent auditors.

Hamps Bio Ltd, formerly known as Hamps Blo Private Limited, has approved the unaudited financial results for the half year ended on 30.09.2025. The approval was given at a Board of Directors meeting held on November 14, 2025, at the corporate office in Surat, Gujarat. The review report, submitted by MG h rtHVS & ASSOCIATES Z& 8154912316, 9265096979 o1 A Chartered Accountants, states that the financial results are in accordance with the Accounting Standard 25 ‘Interim Financial Reporting’ and other generally accepted accounting principles in India.

Hamps Bio Ltd, a company listed on the BSE, has announced the rescheduling of its Board Meeting. The meeting, initially scheduled for November 13, 2025, will now take place on November 14, 2025, at 4:00 PM at the corporate office. The purpose of the meeting is to consider, approve, and take on record the Unaudited Financial Results of the Company for the half-year ended September 30, 2025, in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has informed the BSE about this change in accordance with Regulation 29 of the same regulations.